CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Cellmid Limited Company Snapshot
Cellmid Limited operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Cellmid Limited with three other companies in this sector in Australia: Imugene Limited (2019 sales of 4.54 million Australian Dollars [US$3.12 million] of which 100% was Health technologies), Bionomics Limited (4.03 million Australian Dollars [US$2.77 million] of which 176% was Contract Services), and Immutep Ltd (6.03 million Australian Dollars [US$4.14 million] of which 93% was Cancer Immunotherapy).

Sales Analysis. Cellmid Limited reported sales of A$7.47 million (US$5.12 million) for the fiscal year ending June of 2019. This represents an increase of 29.6% versus 2018, when the company's sales were A$5.76 million. This was the fourth straight year of sales growth at Cellmid Limited.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Cellmid Limited
  Stock Performance Chart for Cellmid Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (11/8/2019): .22
(Figures in Australian Dollars)
1 Week 4.8%   13 Weeks -2.2%  
4 Weeks 4.8%   52 Weeks -35.3%  
 
Cellmid Limited Key Data:
  Ticker: CDY Country: Australia
  Exchanges: Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2019 Sales 7,466,343
(Year Ending Jan 2020).
Employees: N/A
  Currency: Australian Dollars Market Cap: 18,482,085
  Fiscal Yr Ends: June Shares Outstanding: 84,009,475
  Share Type: Ordinary Closely Held Shares: 18,005,118
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.